Lonafarnib/ritonavir with and without pegylated interferon alfa-2a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lonafarnib/ritonavir with and without pegylated interferon alfa-2a, covering 2023-04-14 to 2023-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a [Phase 3]